A traditional Chinese medicine plaster for treating hyperosteogeny and preparation method thereof

A technology for bone hyperplasia and traditional Chinese medicine ointment, which is used in pharmaceutical formulations, medical preparations containing active ingredients, bone diseases, etc., can solve the problems of side effects and cannot improve the patient's environment, and achieve the effects of no toxic side effects and safe medication.

Active Publication Date: 2017-12-19
范孟坡
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The purpose of the present invention is to solve the problem that existing medicines for treating hyperosteogeny have certain side effects and cannot improve the environment in the patient's body, and provide a traditional Chinese medicine plaster for treating hyperosteogeny

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] A traditional Chinese medicine plaster for treating hyperosteogeny, the mass parts of the active ingredients of the Chinese medicinal plaster are: 7 parts of Ligustrum lucidum, 12 parts of tortoise shell, 6 parts of Achyranthes bidentata, 13 parts of Polygonum multiflorum, 9 parts of Dipsacus, 17 parts of Sangjisheng, 11 parts of Clematis, 6 parts of Sea Breeze, 12 parts of Speranthum, 11 parts of Qiannianjian, 6 parts of Xugufeng, 8 parts of Poria, 11 parts of Tongcao, 5 parts of Bianzhu, 13 parts of Bamboo Leaf , Nuxychnium 9 parts, Sappan 8 parts, Drynaria 11 parts, Salvia miltiorrhiza 5 parts, licorice 15 parts.

[0017] Raw materials: Ligustrum lucidum, tortoise shell, Achyranthes bidentata, Polygonum multiflorum, Dipsacus, and Sangjishen. According to the weight ratio of raw materials and saline at 50:1, saline is added for salt frying. The concentration of the saline is 20%. The raw materials Clematis, Caulis, Scutellaria, Qiannianjian, Xugufeng, Poria, Tongcao, ...

Embodiment 2

[0019] A kind of traditional Chinese medicine plaster for treating hyperosteogeny, the mass parts of the active ingredients of the Chinese medicinal plaster are: 28 parts of Ligustrum lucidum, 25 parts of tortoise shell, 29 parts of Achyranthes bidentata, 32 parts of Polygonum multiflorum, 24 parts of Dipsacus, 31 parts of Sangjisheng, 26 parts of Clematis, 23 parts of Sea Breeze, 27 parts of Speranthema, 28 parts of Qiannianjian, 21 parts of Xugufeng, 29 parts of Poria cocos, 31 parts of Tongcao, 26 parts of flat storage, 32 parts of bamboo leaves , Nuxychnium 23 parts, Sappan 24 parts, Drynaria 26 parts, Salvia miltiorrhiza 27 parts, licorice 30 parts.

[0020]Raw materials: Ligustrum lucidum, tortoise shell, Achyranthes bidentata, Polygonum multiflorum, Dipsacus, and Sangjishen. According to the weight ratio of raw materials and saline at 50:1, saline is added for salt frying. The concentration of the saline is 20%. The raw materials Clematis, Caulis, Scutellaria, Qiannianj...

Embodiment 3

[0022] A traditional Chinese medicine plaster for treating hyperosteogeny. The mass parts of active ingredients of the Chinese medicinal plaster are as follows: 13 parts of Ligustrum lucidum, 17 parts of tortoise shell, 14 parts of Achyranthes bidentata, 19 parts of Polygonum multiflorum, 15 parts of Dipsacus, 22 parts of Sangjisheng, 16 parts of Clematis, 12 parts of Sea Breeze, 18 parts of Speranthema, 16 parts of Qiannianjian, 12 parts of Xugufeng, 14 parts of Poria, 18 parts of Tongcao, 10 parts of Bianzhu, 18 parts of Bamboo Leaf , Nuxychnium 13 parts, Sumac 13 parts, Drynaria 17 parts, Salvia miltiorrhiza 12 parts, licorice 20 parts.

[0023] Raw materials: Ligustrum lucidum, tortoise shell, Achyranthes bidentata, Polygonum multiflorum, Dipsacus, and Sangjishen. According to the weight ratio of raw materials and saline at 50:1, saline is added for salt frying. The concentration of the saline is 20%. The raw materials Clematis, Caulis, Scutellaria, Qiannianjian, Xugufeng,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a traditional Chinese medicine paste for treating hyperostosis and a preparation method thereof, relates to the field of medicines for treating hyperostosis and is mainly used for solving the problems of the existing medicines for treating hyperostosis that the side effects are serious and not the disease but symptoms are treated. The active ingredients of the prepared traditional Chinese medicine paste comprise the following active pharmaceutical ingredients in parts by mass: 7-28 parts of glossy privet fruit, 12-25 parts of tortoise plastron, 6-29 parts of radix achyranthis bidentatae, 13-32 parts of radix polygoni multiflori, 9-24 parts of radix dipsaci, 17-31 parts of herba taxilli, 11-26 parts of radix clematidis, 6-23 parts of kadsura pepper stem, 12-27 parts of garden balsam stem, 11-28 parts of obscured homalomena rhizome, 6-21 parts of herba aristolochiae mollissimae, 8-29 parts of poria cocos, 11-31 parts of ricepaperplant pith, 5-26 parts of herba polygoni avicularis, 13-32 parts of bamboo leaves, 9-23 parts of semen strychni, 8-24 parts of sappan wood, 11-26 parts of rhizoma drynariae, 5-27 parts of radix salviae miltiorrhizae and 15-30 parts of radix glycyrrhizae. Clinical practice indicates that the total effective rate of the traditional Chinese medicine paste in treating hyperostosis is over 98% and toxic and side effects are avoided.

Description

technical field [0001] The invention relates to the technical field of drugs for treating hyperosteogeny, in particular to a traditional Chinese medicine plaster for treating hyperosteogeny and a preparation method thereof. Background technique [0002] Osteoarthritis is also known as hyperplastic osteoarthritis, osteoarthritis, degenerative joint disease, senile arthritis, and hypertrophic arthritis. Bone spurs are formed on the edge, synovial hypertrophy and other changes, resulting in bone destruction, causing secondary bone hyperplasia, resulting in joint deformation. When subjected to abnormal loads, it causes joint pain and limited mobility. Traditional Chinese medicine believes that the disease is related to trauma, strain, blood stasis blocking collaterals, feeling wind-cold dampness, internal resistance of phlegm dampness, liver and kidney deficiency, etc. [0003] Bone hyperplasia can be divided into primary and secondary. Primary, also known as idiopathic, is ma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/899A61K9/70A61P19/08A61K35/618
CPCA61K9/7023A61K35/586A61K36/076A61K36/126A61K36/185A61K36/21A61K36/25A61K36/264A61K36/47A61K36/48A61K36/484A61K36/537A61K36/56A61K36/638A61K36/67A61K36/704A61K36/716A61K36/888A61K36/899A61K2236/10A61K2236/15A61K2236/333A61K2236/51A61K2236/53A61K2300/00
Inventor 范孟坡王秀霞
Owner 范孟坡
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap